RE:RE:HEXO / Redecan Pre=Rolls are Top SellersRedecan has experienced the Hexo effect.
Zenabis showed quarterly sales of around $20 million per quarter (Zenabis's problem was never sales - it was debt). Sales since the Hexo acquisition dropped to the $10 to $12 million area.
48N reported $12 million in annual sales - they're down to about $200,000 a quarter
Redecan - sure, they may be #1 in pre-rolls but the market is satiuated and over supplied. Truss Canada is also #1 - but that only translates into monthly sales of around $1 million.
Redecan's overall quarterly sales have dropped significantly - in the first full quarter after the acquisition, Hexo's sales ony increased $5 million including Redecan.
That's only $20 million annually - a huge drop from their previous revenue before Hexo.
All those acquisitions turned bad - Hexo is now a .04 cent USD pre-reverse split.
Rotaluceps - (9/22/2022 6:26:43 PM)
RE:HEXO / Redecan Pre=Rolls are Top Sellers
quinlash wrote:Anyone who researched the Redecan pre-rolls etc would know that Redecan is a top seller in Canada with Redecan also being one of the most profitable. HEXO Corp noted in the corp presentation that they would be focusing more on high margin / high profit product lines and expanding the pre-roll production by as much as 300% in 2022.
Cannabis producer Redecan reported an annual profit before it was acquired by Quebec-based Hexo Corp. in 2021.
However, Redecan, now a Hexo subsidiary, lost CA$91,000 in its latest quarter ended April 2022, according to financial records.